已知有胰腺炎病史的人接受 GLP-1 受体激动剂治疗后的急性胰腺炎发病率。

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2024-08-05 DOI:10.1016/j.diabres.2024.111806

Laura D Lomeli , Alimitha M Kodali , Yumiko Tsushima , Adi E Mehta , Kevin M Pantalone

{"title":"已知有胰腺炎病史的人接受 GLP-1 受体激动剂治疗后的急性胰腺炎发病率。","authors":"Laura D Lomeli , Alimitha M Kodali , Yumiko Tsushima , Adi E Mehta , Kevin M Pantalone","doi":"10.1016/j.diabres.2024.111806","DOIUrl":null,"url":null,"abstract":"<div><p>Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been reported to increase the risk of acute pancreatitis (AP). This real-world study did not observe a higher frequency of AP with GLP-1RA exposure in adults with T2D and a prior history of AP regardless of etiology.</p></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"215 ","pages":"Article 111806"},"PeriodicalIF":6.1000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0168822724007162/pdfft?md5=27059595f804694c0871717e8b9e6d74&pid=1-s2.0-S0168822724007162-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis\",\"authors\":\"Laura D Lomeli , Alimitha M Kodali , Yumiko Tsushima , Adi E Mehta , Kevin M Pantalone\",\"doi\":\"10.1016/j.diabres.2024.111806\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been reported to increase the risk of acute pancreatitis (AP). This real-world study did not observe a higher frequency of AP with GLP-1RA exposure in adults with T2D and a prior history of AP regardless of etiology.</p></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"215 \",\"pages\":\"Article 111806\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0168822724007162/pdfft?md5=27059595f804694c0871717e8b9e6d74&pid=1-s2.0-S0168822724007162-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822724007162\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724007162","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

据报道，胰高血糖素样肽-1 受体激动剂（GLP-1RA）会增加急性胰腺炎（AP）的风险。在这项真实世界研究中，并未观察到患有 T2D 且既往有急性胰腺炎病史的成人（无论病因如何）在接触 GLP-1RA 后发生急性胰腺炎的频率更高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis

Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been reported to increase the risk of acute pancreatitis (AP). This real-world study did not observe a higher frequency of AP with GLP-1RA exposure in adults with T2D and a prior history of AP regardless of etiology.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.